Literature DB >> 27088132

Glioblastoma: Defining Tumor Niches.

Dolores Hambardzumyan1, Gabriele Bergers2.   

Abstract

Glioblastomas (GBM) are one of the most recalcitrant brain tumors because of their aggressive invasive growth and resistance to therapy. They are highly heterogeneous malignancies at both the molecular and histological levels. Specific histological hallmarks including pseudopalisading necrosis and microvascular proliferation distinguish GBM from lower-grade gliomas, and make GBM one of the most hypoxic as well as angiogenic tumors. These microanatomical compartments present specific niches within the tumor microenvironment that regulate metabolic needs, immune surveillance, survival, invasion as well as cancer stem cell maintenance. Here we review features and functions of the distinct GBM niches, detail the different cell constituents and the functional status of the vasculature, and discuss prospects of therapeutically targeting GBM niche constituents.

Entities:  

Keywords:  GBM; astrocytes; cancer stem cells; macrophages; microglial cells; therapy; tumor microenvironment; tumor niches; tumor vasculature

Year:  2015        PMID: 27088132      PMCID: PMC4831073          DOI: 10.1016/j.trecan.2015.10.009

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  110 in total

Review 1.  Neuropathology for the neuroradiologist: palisades and pseudopalisades.

Authors:  F J Wippold; M Lämmle; F Anatelli; J Lennerz; A Perry
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

Review 2.  The neurobiology of gliomas: from cell biology to the development of therapeutic approaches.

Authors:  Manfred Westphal; Katrin Lamszus
Journal:  Nat Rev Neurosci       Date:  2011-08-03       Impact factor: 34.870

3.  Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis.

Authors:  Simon Yona; Ki-Wook Kim; Yochai Wolf; Alexander Mildner; Diana Varol; Michal Breker; Dalit Strauss-Ayali; Sergey Viukov; Martin Guilliams; Alexander Misharin; David A Hume; Harris Perlman; Bernard Malissen; Elazar Zelzer; Steffen Jung
Journal:  Immunity       Date:  2012-12-27       Impact factor: 31.745

4.  Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity.

Authors:  Andrea Casazza; Damya Laoui; Mathias Wenes; Sabrina Rizzolio; Nicklas Bassani; Marco Mambretti; Sofie Deschoemaeker; Jo A Van Ginderachter; Luca Tamagnone; Massimiliano Mazzone
Journal:  Cancer Cell       Date:  2013-12-09       Impact factor: 31.743

Review 5.  Macrophages and therapeutic resistance in cancer.

Authors:  Brian Ruffell; Lisa M Coussens
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

6.  A randomized trial of bevacizumab for newly diagnosed glioblastoma.

Authors:  Mark R Gilbert; James J Dignam; Terri S Armstrong; Jeffrey S Wefel; Deborah T Blumenthal; Michael A Vogelbaum; Howard Colman; Arnab Chakravarti; Stephanie Pugh; Minhee Won; Robert Jeraj; Paul D Brown; Kurt A Jaeckle; David Schiff; Volker W Stieber; David G Brachman; Maria Werner-Wasik; Ivo W Tremont-Lukats; Erik P Sulman; Kenneth D Aldape; Walter J Curran; Minesh P Mehta
Journal:  N Engl J Med       Date:  2014-02-20       Impact factor: 91.245

7.  Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion.

Authors:  David Zagzag; Yevgeniy Lukyanov; Li Lan; M Aktar Ali; Mine Esencay; Olga Mendez; Herman Yee; Evelyn B Voura; Elizabeth W Newcomb
Journal:  Lab Invest       Date:  2006-10-30       Impact factor: 5.662

8.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

Authors:  Zhizhong Li; Shideng Bao; Qiulian Wu; Hui Wang; Christine Eyler; Sith Sathornsumetee; Qing Shi; Yiting Cao; Justin Lathia; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

Review 9.  The cancer genome.

Authors:  Michael R Stratton; Peter J Campbell; P Andrew Futreal
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

10.  Clinical significance of vasculogenic mimicry in human gliomas.

Authors:  Xiao-mei Liu; Qing-ping Zhang; Yong-gao Mu; Xiang-hen Zhang; Ke Sai; Jesse Chung-Sean Pang; Ho-Keung Ng; Zhong-ping Chen
Journal:  J Neurooncol       Date:  2011-04-30       Impact factor: 4.130

View more
  143 in total

Review 1.  Glioblastoma niches: from the concept to the phenotypical reality.

Authors:  Davide Schiffer; Marta Mellai; Enrica Bovio; Ilaria Bisogno; Cristina Casalone; Laura Annovazzi
Journal:  Neurol Sci       Date:  2018-05-08       Impact factor: 3.307

2.  Intravital 2-photon imaging reveals distinct morphology and infiltrative properties of glioblastoma-associated macrophages.

Authors:  Zhihong Chen; James L Ross; Dolores Hambardzumyan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-24       Impact factor: 11.205

3.  Tumoricidal stem cell therapy enables killing in novel hybrid models of heterogeneous glioblastoma.

Authors:  Andrew B Satterlee; Denise E Dunn; Donald C Lo; Simon Khagi; Shawn Hingtgen
Journal:  Neuro Oncol       Date:  2019-12-17       Impact factor: 12.300

4.  Widespread gene transfer to malignant gliomas with In vitro-to-In vivo correlation.

Authors:  Karina Negron; Namir Khalasawi; Billy Lu; Chi-Ying Ho; Jason Lee; Siddharth Shenoy; Hai-Quan Mao; Tza-Huei Wang; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2019-04-09       Impact factor: 9.776

5.  A Biomechanical Model of Tumor-Induced Intracranial Pressure and Edema in Brain Tissue.

Authors:  Inmaculada C Sorribes; Matthew N J Moore; Helen M Byrne; Harsh V Jain
Journal:  Biophys J       Date:  2019-03-23       Impact factor: 4.033

6.  A three-dimensional (3D) organotypic microfluidic model for glioma stem cells - Vascular interactions.

Authors:  Danh Truong; Roberto Fiorelli; Eric S Barrientos; Ernesto Luna Melendez; Nader Sanai; Shwetal Mehta; Mehdi Nikkhah
Journal:  Biomaterials       Date:  2018-07-30       Impact factor: 12.479

7.  Physiologic MR imaging of the tumor microenvironment revealed switching of metabolic phenotype upon recurrence of glioblastoma in humans.

Authors:  Andreas Stadlbauer; Stefan Oberndorfer; Max Zimmermann; Bertold Renner; Michael Buchfelder; Gertraud Heinz; Arnd Doerfler; Andrea Kleindienst; Karl Roessler
Journal:  J Cereb Blood Flow Metab       Date:  2019-02-07       Impact factor: 6.200

Review 8.  3D bioprinting of glioblastoma models.

Authors:  Carolina Parra-Cantu; Wanlu Li; Alfredo Quiñones-Hinojosa; Yu Shrike Zhang
Journal:  J 3D Print Med       Date:  2020-10-28

9.  A gelatin hydrogel to study endometrial angiogenesis and trophoblast invasion.

Authors:  Samantha G Zambuto; Kathryn B H Clancy; Brendan A C Harley
Journal:  Interface Focus       Date:  2019-08-16       Impact factor: 3.906

Review 10.  An overview of MCT1 and MCT4 in GBM: small molecule transporters with large implications.

Authors:  Simon J Park; Chase P Smith; Ryan R Wilbur; Charles P Cain; Sankeerth R Kallu; Srijan Valasapalli; Arpit Sahoo; Maheedhara R Guda; Andrew J Tsung; Kiran K Velpula
Journal:  Am J Cancer Res       Date:  2018-10-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.